|
|
||||||||
1From the Department of Biological Sciences, College of Optometry, State University of New York, New York City, New York; the 2Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts; and the 3Department of Ophthalmology, Wayne State University of Medicine, Detroit, Michigan.
| Abstract |
|---|
|
|
|---|
METHODS. Expression of asialoGM1 and TLR5 was detected in SV40 HCECs by Western blot and flow cytometry analyses and their association by coimmunoprecipitation. Single-cell fluorescence imaging was used to measure intracellular free Ca2+ transients in fura-2loaded cells. The enzyme-linked immunosorbent assay (ELISA) was used to quantify IL-8 production in both cultured and primary HCECs.
RESULTS. The HCECs expressed both asialoGM1 and TLR5 receptors. Ligation of asialoGM1 resulted in proteinprotein interaction with TLR5, followed by transient increases in Ca2+ influx through L-type voltage-dependent Ca2+ channels. This led to P2Y receptor stimulation along with membrane depolarization, resulting from increases in ATP release into the medium. Intracellular Ca2+ transients led to time-dependent extracellular signal-regulated kinase (ERK) MAPK pathway stimulation, followed by a 9.5-fold increase in IL-8 release. Similarly, in primary HCECs, asialoGM1 receptor stimulation resulted in an 8.1-fold increase. With a TLR5 neutralizing antibody, no asialoGM1-induced increases in IL-8 release occurred, and this response was not suppressed in the presence of a TLR2 neutralizing antibody.
CONCLUSIONS. IL-8 release by HCECs is mediated through ligand-induced asialoGM1 proteinprotein interactions with TLR5. This response is dependent on ATP efflux into the medium, followed by P2Y receptor stimulation. Such activation, in turn, results in increases in Ca2+ influx through L-type voltage-dependent Ca2+ channels, as well as stimulation of the ERK pathway.
B, and production of proinflammatory cytokines.3 4 11 12 13 Release of these cytokines can augment the infection and contribute to corneal destruction.14 15
Asialylated glycolipids, such as asialoGM1, act as coreceptors for many pathogens, including Haemophilus influenzae, Staphylococcus aureus, Streptococcus pneumoniae, Klebsiella pneumoniae, Escherichia coli, and PA,5 16 as well as PAMPs such as pilin and flagellin.5 Recognition of PAMPs by asialoGM1 can be mimicked by ligation with asialoGM1 antibody. This interaction stimulates (1) nuclear translocation of NF-
B, (2) phosphorylation of extracellular signal-related kinase (ERK)1/2,4 and (3) expression of the mucin (MUC-2)9 10 and interleukin (IL)-8 genes.17 Because asialoGM1 lacks transmembrane and intracellular domains, it is incapable of direct contact with cytoplasmic signaling molecules. A possible link between asialoGM1 and downstream signaling components is an assemblage of different TLRs.
TLRs are an evolutionarily conserved family of pattern-recognition receptors that function in innate immunity through recognition of PAMPs.6 7 8 To date, 11 TLRs types have been identified.18 19 20 TLR2 agonists include a variety of bacterial cell wall products, such as peptidoglycan (PGN), lipoteichoic acid (LTA), and lipoproteins,18 19 20 whereas TLR3 agonists are viral double-stranded (ds)RNAs.21 TLR4 agonists include Gram-negative bacterial lipopolysaccharide (LPS), respiratory syncytial virus protein F, and the plant product taxol.22 23 Bacterial flagellin has been identified as a TLR5 agonist,24 and unmethylated CpG-containing DNA as a TLR9 agonist.25 In the cornea, the expression of TLR2, -4, -5, and -9 have been documented.3 26 27 Furthermore, colocalization of TLRs and gangliosides has been described in many cell types to function in mediating signal transduction.28 TLRs are possible candidates for interaction with asialoGM1 as coreceptors.
CECs are an important component of mucosal defenses, expressing chemokines and cytokines to direct the influx and activation of phagocytic cells in response to bacterial pathogens. Hence, part of the corneal epithelial barrier function depends on its ability to sense and respond to danger signals. Although asialoGM1 serves as a receptor for detecting many pathogens in some tissues,5 its presence in the corneal epithelium is controversial.29 30 Earlier studies by Hazlett et al.29 provided evidence that asialoGM1 is present in the mouse and bovine31 corneas, where it serves as a receptor for PA and is spatially localized in the wound site. However, immunohistochemical and thin-layer chromatogram immunostaining suggest that the isolated rabbit corneal epithelium contains no detectable levels of asialoGM1, even after attempts to expose potential cryptic sites with trypsin, PA, or PA exoproducts.30 Furthermore, preliminary immunohistochemical analyses indicate that no asialoGM1 is present in human corneas.30 Recently, Yamamoto et al.32 showed that asialoGM1, as a constituent of lipid rafts, participates in PA internalization. Of significance, the more proximal components of the epithelial cell signaling cascade, the receptor, and the kinases involved in signal transduction in the cornea have never been characterized.
In this study, we determined the effect of asialoGM1 ligation in SV40-immortalized human corneal epithelial cells (HCECs) on Ca2+ mobilization, ERK1/2 phosphorylation, and proinflammatory IL-8 production. We demonstrated that ligation of asialoGM1 induces its heterodimerization with TLR5, inducing adenosine 5'-triphosphate (ATP) release and in turn P2Y receptor stimulation, which leads to L-type voltage-dependent Ca2+ channel activation followed by transient increases in intracellular [Ca2+]. We also showed that subsequent activation of the ERK limb of MAPK cascade leads to very similar increases in release of IL-8 in both SV40-immortalized and primary HCECs. This interaction between asialoGM1 and TLR5 is specific, since it was abrogated during exposure to TLR5 blocking antibody, and TLR2 neutralization did not suppress IL-8 release.
| Methods |
|---|
|
|
|---|
Western Blot Analysis
HCECs were pretreated with U0126 (Cell Signaling Technology, Beverly, MA), EGTA, nifedipine, or phosphate-buffered saline (PBS) and then treated with anti-asialoGM1 antibody. After treatment, cells were washed twice with ice-cold PBS (pH 7.4) and lysed for at least 5 minutes on ice in whole cell lysis buffer (20 mM Tris [pH 7.5], 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 2.5 mM sodium pyrophosphate, 1 mM ß-glycerolphosphate, and 1 mM Na3VO4), with a protease inhibitor mixture (1 mM phenylmethylsulfonyl fluoride [PMSF], 1 mM benzamide, 10 µg/mL leupeptin, and 10 µg/mL aprotinin). Cells were harvested by scraping followed by sonication (three bursts at 40 mV for 10 seconds), and cell lysates were clarified by centrifugation at 4°C for 15 minutes at 13,000 rpm. Protein concentrations of the lysates were measured with a bicinchoninic acid assay (Micro BCA protein assay kit; Pierce Biotechnology, Rockford, IL), and equal amounts of total protein were fractionated on 10% sodium dodecyl sulfate (SDS)-polyacrylamide gels. After semidry transfer to polyvinylidene difluoride (PVDF) membranes, the membranes were blocked with PBS containing 0.1% Tween-20 (PBS-T) and 5% nonfat dry milk (Carnation, Nestlé USA, Glendale, CA) for 1 hour at room temperature and then incubated with specific antibodies for 2 hours at room temperature or overnight at 4°C. The antibodies used were: anti-asialoGM1 (1:50,0001:100,000 dilution; Wako Chemical, Richmond, VA), anti-TLR5 (1:1000), anti-phospho-ERK1/2 (1:1000), and anti-ERK1/2 (1:2000; Santa Cruz Biotechnology, Santa Cruz, CA). After primary antibody incubation, PVDF membranes were washed three times with 5% nonfat dry milk in PBS-T and then incubated with an appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (1:2,0001:10,000 dilution; Santa Cruz Biotechnology) for 1 hour at room temperature. After successive washings, bound antibodies were visualized with an enhanced chemiluminescence system (ECL Plus Western Blot detection system; GE Healthcare, Piscataway, NJ).
Flow Cytometry Analysis
Cell surface expression of asialoGM1 and TLR5 was determined by flow cytometry (Epics XL; Beckman-Coulter, Fullerton, CA) with laser power of 5.76 mW. The instrument was calibrated before each measurement with standardized fluorescent particles (Immunocheck; AMAC, Inc. Westbrook, ME). Fluorescence signals of cells were measured simultaneously by three photomultiplier tubes and optical filters and are expressed as the mean log fluorescence intensity of the cell population within the gate. The HCECs were incubated with an anti-asialoGM1 and TLR5 antibody on ice for 60 minutes, washed three times, incubated with a phycoerythrin (PE)-conjugated secondary antibody for 30 minutes on ice protected from light, fixed in lysing solution (Optilyse; Beckman-Coulter) at room temperature for 5 to 10 minutes, and analyzed by flow cytometry. The cells were initially identified by the characteristic forward- and side-scatter parameters on unstained cells and confirmed by staining with PE-conjugated primary anti-human HLA-DR (Beckman-Coulter). Data are expressed as the mean relative fluorescence units (RFU) and percentage of cells staining positively. Isotype primary conjugated antibodies served as a negative control. Samples were prepared and analyzed in duplicate, and a minimum of 5000 cells were counted from each sample.
Fluorescence Microscopy
Cells were subcultured on 22-mm diameter glass coverslips (Fisher Scientific, Pittsburgh, PA), loaded with 2 µM Fura-2/AM (Invitrogen-Molecular Probes, Eugene, OR), with or without inhibitors (nifedipine, apyrase [Grade III], ARL67156, suramin, or PPADS) at 37°C for 30 minutes, then washed four times with Ringers solution (141 mM NaCl, 4.2 mM KCl, 2 mM KH2PO4, 1 mM MgCl2.6H2O, 0.8 mM CaCl2, 5.5 mM glucose, and 10 mM HEPES, 300 mOsmol/L [pH 7.4]), Ca2+-free counterpart solution buffered by 0.5 mM EGTA or Cl-free solution (141.6 mM D-gluconic acid sodium salt, 2.5 mM K2SO4, 2 mM MgSO4.7 H2O, 5 mM glucose, 5.4 mM CaSO4.2H2O, and 5.3 mM HEPES [pH 7.4], 300 mOsmol/L). Cells were alternately illuminated with 340 and 380 nm and their emission at 510 nm was monitored every 5 seconds with an inverted microscope (Diaphot 200; Nikon, Tokyo, Japan) and a digital charge coupled device (CCD) camera (model 1400 microimager; Xillix, Vancouver, British Columbia, Canada). Image-analysis software (Ratio Tool; Inovision, Durham, NC) was used to record and analyze fluorescence ratios. In a given microscopic field, 25 individual cells were chosen for monitoring, only if they had a comparatively large cytoplasmic/nuclear ratio and homogeneous brightness. At least five coverslips were examined for each condition. Results were plotted as
F340/F380 ± SEM from at least five independent experiments.
Determination of IL-8 Secretion
Secretion of proinflammatory cytokines was determined with protein cytokine arrays, and the amount of IL-8 was measured using an enzyme-linked immunosorbent assay (ELISA). Immortalized HCECs and primary HCECs were plated in 35-mm cell culture plates. After 24 hours of growth factor starvation, cells were washed twice with PBS and then exposed to the indicated condition for 30 minutes before the cells were stimulated with anti-asialoGM1 antibody (1:80) for 8 hours. Supernatants were harvested and centrifuged at 4000 rpm for 3 minutes, to remove cell debris. Each supernatant was stored at 80°C until analysis. Protein concentration of each cell lysate was determined using the BCA protein assay kit. Protein microwell TH1/TH2 cytokine arrays were immobilized with nine different capture antibodies: IL-2, -4, -5, -8, -10, -12, and -13; interferon (IFN)-
; and tumor necrosis factor (TNF)-
(Pierce Biotechnology). IL-8 ELISA (R&D Systems, Minneapolis, MN) was performed according to the manufacturers instructions. The amount of IL-8 in the culture medium was normalized to the total amount of cellular protein lysed with 5% SDS and 0.5 N NaOH. Results are expressed as mean picograms of IL-8 per milligram cell lysate ± SEM (n = 3).
Coimmunoprecipitation
Cells grown to 85% to 90% confluence in 100-mm plates (Fisher Scientific) were washed twice with ice-cold PBS and then lysed with 1 mL of radioimmunoprecipitation assay (RIPA) buffer (150 mM NaCl, 20 mM Tris [pH 7.5], 1% Triton X-100, 0.5% sodium deoxycholate, 1 mM EDTA, and 0.1% SDS) with a protease and phosphatase inhibitor mixture (1 mM PMSF, 10 µg/mL aprotinin, 10 µg/mL leupeptin, 1 µg/mL pepstatin, 1 mM sodium fluoride, and 1 mM sodium orthovanadate) for at least 20 minutes on ice at 4°C. After the cells were harvested by scraping and sonication, the sample was centrifuged at 13,000 rpm at 4°C for 15 minutes to remove debris. Nonspecific proteins in the supernatant were removed by preclearing the sample with 50 µL of 50% vol/vol of Proteins A and G (Santa Cruz Biotechnology) with 1 µg of the appropriate control IgG, for 30 minutes at 4°C, followed by centrifugation (2500 rpm for 30 seconds). The protein concentration of the supernatant was determined with the BCA protein assay kit. Equal amounts of protein (1300 µg) were subjected to immunoprecipitation with 6 µg of anti-TLR5, 15 µg of anti-asialoGM1, or 15 µg nonspecific immunoglobulin (normal mouse control IgG; Santa Cruz Biotechnology) and 20 µL of Protein A/G mixture (1:1) or with the beads alone at 4°C overnight. Immunoprecipitates were washed with RIPA buffer three times and PBS once, dissolved in 60 µL of 2x sample buffer (12.5 mM Tris [pH 6.8], 4% SDS, 20% glycerol, 2.5% ß-mercaptoethanol, 0.1% bromphenol blue), boiled for 10 minutes, and centrifuged at 10,000 rpm for 2 minutes at 4°C to remove the beads. The samples were then subjected to SDS-PAGE and Western blot analysis.
Statistical Analysis
Data are expressed as the mean ± SEM of experimental sets, each of which were repeated at least three times, unless otherwise indicated. All statistical analyses were performed by one-way ANOVA (Statistica 6.0; StatSoft, Tulsa, OK) with the Fisher least-significant difference (LSD) post hoc probability matrix, unless otherwise specified, and P < 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
To confirm the involvement of L-type voltage-dependent Ca2+ channel activation in mediating anti-asialoGM1 antibodyinduced Ca2+ transients, we incubated the cells in Cl-free Ringers solution. Such activation is dependent on membrane depolarization to less than 30 mV, resulting from the cAMP-mediated stimulation of net Cl transport. When net Cl transport activity is eliminated in Cl-free Ringers, TLR5 receptor activation cannot induce L-type Ca2+ channel activation. Such stimulation is obviated because despite adenylate cyclasemediated cAMP formation, the membrane voltage cannot be depolarized to a level sufficient to activate L-type Ca2+ channel activity. The results shown in Figure 2C are consistent with this formulation, since there was a near equivalence between the diminution of the anti-asialoGM1 antibodyinduced Ca2+ transients in Cl-free Ringers and those measured during exposure to nifedipine. This agreement provides further support that TLR5-induced Ca2+ transients stem from stimulation of L-type Ca2+ activity.
Involvement of ATP on Transduction of Ca2+ Signals from AsialoGM1
To determine whether asialoGM1 ligation induces downstream Ca2+ transients through ATP release into the medium, the effects of apyrase (an ATP dephosphatase) and ARL67156 (an ectonucleotidase inhibitor) on Ca2+ mobilization after asialoGM1 ligation were studied. ATP
-S elicited dose-dependent increases in [Ca2+]i (Figs. 3A 3B) . Apyrase suppressed in a dose-dependent manner the anti-asialoGM1 antibodyinduced [Ca2+]i increase (Fig. 3C ; F5,24 = 11.7417, P < 0.00001), thus indicating a role for ATP. To confirm further a role for ATP, the cells were preincubated with 100 µM of the 5'-ectonucleotidase inhibitor ARL67156 for 30 minutes before the simultaneous applications of 1:160 anti-asialoGM1 antibody and 100 µM ARL67156. This inhibitor increased the efficacy of anti-asialoGM1 antibodyinduced Ca2+ mobilization, presumably due to suppression of ATP hydrolysis (Fig. 3D ; F4,20 = 25.6559, P < 0.00001; Fisher LSD P < 0.005). Furthermore, the presence of the P2 receptor antagonists100 µM suramin and 100 µM PPADSsignificantly reduced anti-asialoGM1 antibodyinduced Ca2+ transients (Fig. 3D ; F4,20 = 25.6559, P < 0.00001; Fisher LSD P < 0.00001). These results are consistent with those described in human lung epithelial cells in which asialoGM1 ligation promotes ATP release and induces P2 receptor stimulation followed by transients increases in [Ca2+]i.10
|
|
Effect of AsialoGM1 Ligation on IL8 Secretion
To assess the biological relevance of anti-asialoGM1 antibodyinduced Ca2+ mobilization, we measured the effect of anti-asialoGM1 antibody on proinflammatory cytokine production (secretion) with a protein microwell array. Of the nine cytokines examined, only IL-8 secretion was detected (data not shown). ELISA was performed to quantify the secretion of IL-8 in immortalized HCECs and primary HCECs. Both cell lines constitutively secreted IL-8. Increased amounts of IL-8 were detected after 8 hours of exposure to a 1:80 dilution of the antibody agonist (F11,24 = 54.8384, P < 0.0001; Fisher LSD P < 0.0001). After 8 hours, the amounts of IL-8 accumulated in the culture medium of immortalized HCECs and primary HCECs stimulated with asialoGM1 were 9.5 and 8.1 times, respectively, more than that in their control cell medium.
AsialoGM1-Mediated IL-8 Release
To determine the dependency of IL-8 secretion on Ca2+ mobilization after asialoGM1 ligation, the effects of Ca2+ chelators on IL-8 secretion were determined. In the absence of extracellular Ca2+ or presence of the anti-TLR5 antibody, anti-asialoGM1 antibodyinduced secretion of IL-8 was inhibited (Fig. 5) . Pretreatment with anti-TLR2 antibody did not prevent asialoGM1-induced secretion of IL-8, suggesting that the release of AGM1-mediated release of this chemokine is solely dependent on its interaction with TLR5. Moreover, U0126 (10 µM) reduced anti-asialoGM1 antibodyinduced IL-8 accumulation by 86%. In parallel experiments, similar results were found for IL-8 secretion in primary HCECs. These data suggest that asialoGM1 ligation stimulates IL-8 secretion, which is mediated by TLR5 and not TLR2. Furthermore, asialoGM1-mediated Ca2+ influx from the extracellular space stimulates the ERK pathway.
|
|
| Discussion |
|---|
|
|
|---|
|
AsialoGM1 has an exposed GalNAcß1-4Gal moiety that serves as a receptor for a large number of pathogens.16 Owing to the corneal epitheliums lack of transmembrane and cytoplasmic components, the link between ligand recognition and downstream kinase activation in the corneal epithelium remains to be clarified. In airway epithelial cells, asialoGM1 ligation promotes extracellular ATP release, followed by autocrine activation of nucleotide receptors, possibly P2Y, resulting in activation of phospholipase C (PLC), Ca2+ mobilization, phosphorylation of ERK1/2 and activation of mucin transcription.9 The mechanism of ATP release, whether by exocytosis or by a pumping out by members of the ATP-binding cassette (ABC) transporter family, remains unknown. Moreover, in parainfluenza viral infections, activation of Cl secretion and inhibition of Na+ absorption across the tracheal epithelium have been reported.40 These changes in ion transport activity result in inhibition of volume regulation and are a consequence of binding to a neuraminidase-insensitive glycolipid, possibly asialoGM1, triggering the release of ATP, which then acts in an autocrine fashion on apical P2Y receptors to produce the aforementioned changes in ion transport.40 Changes in Ca2+ transient patterns of activation in the presence of apyrase, ARL67156, and P2 receptor antagonists confirm that asialoGM1 ligation in HCECs cause extracellular ATP release and binding to P2 receptors.
Purinergic receptors represent a potential link between asialoGM1 ligation and downstream signaling components.9 10 40 On binding of ATP to purinergic receptors, large Ca2+ oscillations are induced.41 42 These increases in cytosolic Ca2+ are generated by P2X or P2Y receptor activation, which occur via distinct mechanisms.43 P2X receptors, which play an important role in excitable cell types, are ligand-gated ion channels that allow Ca2+ influx from the extracellular space after nucleotide binding.44 On the other hand, P2Y receptors are G-protein coupled receptors (GPCRs) that stimulate release of intracellular Ca2+ stores through PLC-mediated PIP2 hydrolysis and activation of the IP3 pathway.44 These receptors produce a biphasic Ca2+ response in which the initial depletion of intracellular Ca2+ stores leads to a sustained Ca2+ release due to the opening of specific store-operated voltage-independent Ca2+ channels in the plasma membrane that allow Ca2+ entry from the extracellular space.45
The innate immune response to microbes consists of an assortment of soluble components including cytokines, chemokines, and antimicrobial peptides.46 Epithelial cells produce IL-8 in response to PA challenge through activation of NF-
B and transcription of the IL-8 gene.17 47 In airway epithelial cells, intracellular Ca2+ transients mediate IL-8 production; cells pretreated with BAPTA/AM to chelate intracellular Ca2+ had significantly reduced PA-induced IL-8 responses, whereas EGTA, an extracellular Ca2+ chelator, and NiCl2, an external Ca2+ channel blocker, did not inhibit IL-8 secretion.4 Moreover, BAPTA/AM and thapsigargin, which deplete Ca2+ stores by blocking Ca2+ ATPases in the endoplasmic reticulum and clamping intracellular Ca2+ concentration, respectively, significantly reduce anti-asialoGM1 antibodyinduced ERK1/2 phosphorylation as well as MUC-2 production in airway epithelial cells.9 Our results indicate that, in immortalized and primary HCECs, IL-8 productioninduced by asialoGM1 ligationis mediated by Ca2+ influx, suggesting a tissue-specific signaling cascade.
In HCECs, anti-asialoGM1 antibodyinduced Ca2+ transients are a result of Ca2+ influx from the extracellular space after cAMP-mediated increases in net transepithelial Cl transport activity. This response was suppressed in Cl-free medium, since the membrane voltage remained too negative for L-type voltage-dependent Ca2+ channel stimulation. In this condition, despite ATP release after TLR5 stimulation, its hydrolysis by adenylate cyclase to produce cAMP had no depolarizing effect on membrane voltage in a Cl-free medium. Alternatively, blockage of volume regulation clamped the membrane voltage at levels that were too hyperpolarized in another system, which prevented asialoGM1 coreceptorinduced increases in Ca2+ influx through stimulation of L-type voltage-dependent Ca2+ channel activity.40 Taken together, the evidence shows that, although asialoGM1 participates in innate immunity, its effects are mediated by different pathways in different tissues.
Another potential transmembrane link between asialoGM1 ligation and downstream signaling events are the TLRs. In airway epithelial cells, the signaling capabilities of TLR2 are amplified, through its association with asialoGM1 within the context of lipid rafts, to provide a broadly responsive signaling complex that initiates the host response to potential bacterial infection.13 Our characterization of Ca2+ transients indicate that both TLR2 (PGN, LTA Gram-positive bacteria cell wall components) and TLR4 (LPS and lipid A Gram-negative bacteria cell wall components) agonists did not elicit Ca2+ mobilization and that anti-asialoGM1 antibodyinduced increases in [Ca2+]i are not potentiated by TLR2 agonists (data not shown). Similarly, inhibition of TLR2 did not prevent anti-asialoGM1 antibodyinduced increase in IL-8 secretion. This suggests that TLRs2 and -4 are unlikely candidates for asialoGM1 coreceptors, and that a tissue-specific relationship may exist to account for differences in pathogen recognition.
Another possible candidate for a receptor complex is TLR5. Recent studies have shown that flagellasurface structures that confer motilityenhance the pathogenicity of certain organisms, either by promoting adhesion to the host tissues or by directly activating host inflammatory signaling pathways.34 48 49 50 PA elaborates a multitude of factors, including flagella.14 It has been demonstrated that flagella bind specifically to host cell glycosphingolipid asialoGM1 and that binding is essential for epithelial cell invasion and cytotoxicity.5 14 In airway epithelial infection by PA, flagella initially localized with asialoGM1, inducing TLR5 mobilization to the apical cell surface and its subsequent colocalization with superficial flagella.12 Flagella-induced Ca2+ fluxes induce activation of Src, Ras, ERK1/2, and NF-
B through asialoGM1, TLR2, and TLR5, which is dependent on the availability of exposed receptors on the apical surface of polarized airway epithelial cells.12
Finally, within the specific context of IL-8 production induced by pathogenic bacteria or their PAMPs, significant common themes are notable. For example, the signaling pathway by which asialoGM1 ligands stimulate IL-8 production51 is similar to that stimulated by flagellin,12 52 53 LPS,54 and PGN/LTA,12 55 in that it requires activation of NF-
B and MAPKs, especially ERK1/2. Our results suggest a role for the ERK limb of the MAPK cascade, consistent with findings in previous studies. In agreement with results in previous studies, ours suggest a role for the ERK pathway of the MAPK cascade. Convergence of these bacterial recognition pathways on these kinases represents a coordinated innate immune response.
In summary, our studies suggest that HCECs can initiate immune responses via asialoGM1 ligation, thus resulting in the clearing of pathogens and, potentially, the elimination of the excessive inflammatory response that result in corneal scarring and loss of vision. Understanding the molecular events of bacterialepithelial interactions and the inflammatory consequences of asialoGM1 ligation may permit the development of novel, specific therapies that can promote innate defenses and prevent some of the destructive sequelae of ocular bacterial infections.
| Acknowledgements |
|---|
| Footnotes |
|---|
Supported by National Eye Institute Grant EY04795.
Submitted for publication March 9, 2006; revised July 5, 2006; accepted September 22, 2006.
Disclosure: J.W. Du, None; F. Zhang, None; J.E. Capó-Aponte, None; S.D. Tachado, None; J. Zhang, None; F.-S.X. Yu, None; R.A. Sack, None; H. Koziel, None; P.S. Reinach, None
The publication costs of this article were defrayed in part by page charge payment. This article must therefore be marked "advertisement" in accordance with 18 U.S.C.
1734 solely to indicate this fact.
Corresponding author: Peter S. Reinach, Department of Biological Sciences, State University of New York, State College of Optometry, 33 West 42nd Street, New York, NY 10036; preinach{at}sunyopt.edu.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
B. Koller, M. Kappler, P. Latzin, A. Gaggar, M. Schreiner, S. Takyar, M. Kormann, M. Kabesch, D. Roos, M. Griese, et al. TLR Expression on Neutrophils at the Pulmonary Site of Infection: TLR1/TLR2-Mediated Up-Regulation of TLR5 Expression in Cystic Fibrosis Lung Disease J. Immunol., August 15, 2008; 181(4): 2753 - 2763. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Liang, M. Wang, R. I. Tapping, V. Stepensky, H. F. Nawar, M. Triantafilou, K. Triantafilou, T. D. Connell, and G. Hajishengallis Ganglioside GD1a Is an Essential Coreceptor for Toll-like Receptor 2 Signaling in Response to the B subunit of Type IIb Enterotoxin J. Biol. Chem., March 9, 2007; 282(10): 7532 - 7542. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||